H   Hybrid

Zkittlez

Zkittlez is a AAA-grade indica-dominant hybrid with 15% THC, bred from Grape Ape and Grapefruit, offering a sweet berry and citrus flavour profile.

From $35 / 3.5g
Amount Bigger sizes, lower per-unit price
  • Same-night GTA delivery — order by 9pm, we knock by 10.
  • Discreet & unbranded — plain packaging, nothing on the outside.
  • e-Transfer, card or cash — pay online by e-Transfer, or by card or cash at the door. No card data stored online, ever.
Details

About Zkittlez

Zkittlez is an indica-dominant hybrid flower bred from Grape Ape and Grapefruit lineage. Rated AAA grade, it is a well-documented strain recognised for its flavour-forward profile and its First Place wins for Best Indica at the 2015 Cannabis Cups in both San Francisco and Michigan. With 15% THC, it sits in a mid-range potency bracket suited to a wide range of adult consumers.

Product Details

Zkittlez is sold as AAA-grade dried flower. The buds are characteristically large and dense, presenting in deep olive-green tones with rich amber pistils running throughout. A heavy coating of white trichomes covers the surface, which is a reliable visual indicator of resin production and careful cultivation. The overall structure and colouration reflect consistent growing and handling practices expected of a AAA classification.

Flavour & Aroma

The aroma opens with a sweet, tropical berry character layered over earthy undertones and a subtle herbal note. On the palate, the flavour follows closely — leading with a candy-like sweetness that transitions into a crisp citrus finish. The citrus quality lingers after exhale, rounding out each session with a clean, fruit-forward close. The combination of berry, earth, herb, and citrus gives Zkittlez a layered and recognisable flavour profile that holds up across different consumption methods.

Effects & Use Type

As an indica-dominant hybrid at 15% THC, Zkittlez produces a mood-lifting effect accompanied by a body sensation that is calming without being fully sedating. Users can expect a mellow, functional state during the earlier portion of the session, with a softer, more restful quality as the effects wind down. The relatively moderate THC level makes the onset gradual and manageable, which is practical for adults who want to remain reasonably alert while still experiencing full-body calm. It is a suitable choice for evening use or slower-paced daytime settings.

Who This Product Is For

Zkittlez suits adults who want an indica-dominant hybrid with a fruit-forward flavour profile and a balanced, moderate THC level. It is an accessible option for newer cannabis consumers who prefer a gentler introduction to indica effects, as well as seasoned adults who favour flavour and smooth, even effects over raw potency. Whether you are in Toronto, Mississauga, Brampton, Markham, Vaughan, or elsewhere across the GTA, Sixtall delivers Zkittlez and a full range of cannabis products directly to your door through same-day home delivery — available to adults 19 and older.

Keep browsing

More hybrid

View N95
N95
H   Hybrid

N95

N95-AA is a balanced hybrid dried cannabis flower with a fuel-forward aroma and subtle sweetness, suited to a range of adult routines.

$30 / 7g
Add +
View Miracle Alien Cookies (Greenhouse)
Miracle Alien Cookies (Greenhouse)
H   Hybrid

Miracle Alien Cookies (Greenhouse)

Miracle Alien Cookies is a greenhouse-grown 50/50 hybrid with 14–20% THC, sour citrus and diesel aroma, and a balanced cerebral and body effect.

$25 / 7g
Add +
View Unicorn Poop
Unicorn Poop
H   Hybrid

Unicorn Poop

Unicorn Poop is a balanced hybrid flower with 23–24% THC, sweet citrus and berry flavour, and even cerebral and body effects.

$40 / 7g
Add +
View Apple Fritter
Apple Fritter
H   Hybrid

Apple Fritter

Apple Fritter is a balanced hybrid strain, a cross of Sour Apple and Animal Cookies, with THC ranging from 21%–26%.

$25 / 3.5g
Add +

Sixtall sells to adults 19+ only. Please consume responsibly, keep all products out of reach of children and pets, and never drive after use. Products have not been evaluated for the treatment of any medical condition.

Last updated July 2026